Valproic acid prenatal exposure. Association with lipomyelomeningocele

Related Experiment Videos

B S Carter1, J M Stewart

  • 1Department of Pediatrics, University of Colorado School of Medicine, Denver.

Clinical Pediatrics
|February 1, 1989
PubMed

Insights

Maternal use of valproic acid during pregnancy can cause birth defects. This study reports a new association between valproic acid and closed neural tube defects, specifically lipomyelomeningocele, in siblings.

Area of Science:

  • Neurology
  • Teratology
  • Pediatric Surgery

Background:

  • Valproic acid is a commonly prescribed anticonvulsant medication.
  • Maternal valproic acid use in pregnancy is a known risk factor for open neural tube defects.
  • The association with closed neural tube defects remains less understood.

Observation:

  • A family presented with two siblings exhibiting different congenital malformations.
  • Both siblings were exposed to maternal valproic acid and other anticonvulsants during gestation.
  • One sibling was diagnosed with a lipomyelomeningocele, a type of closed neural tube defect.

Findings:

  • This case report details a novel association between maternal valproic acid exposure and the development of closed neural tube defects, specifically lipomyelomeningocele.
  • The findings suggest valproic acid may contribute to a broader spectrum of neural tube defects than previously recognized.
  • Sibling malformations highlight potential genetic or environmental factors interacting with teratogenic exposures.

Implications:

  • The findings underscore the importance of counseling pregnant individuals on the risks of valproic acid and other anticonvulsants.
  • Early recognition and surgical intervention for lipomyelomeningocele are crucial for optimal patient outcomes.
  • Further research is warranted to elucidate the mechanisms underlying valproic acid-induced teratogenicity and its impact on various neural tube defect types.

Related Concept Videos